Salivary Gland Tumors

Descriptive text is not available for this image Basics

Salivary gland tumors consist of benign or malignant neoplasms of the major and minor salivary glands. Tumors may be mimicked clinically by a variety of inflammatory or infectious disorders:

  • Major: parotid, submaxillary, sublingual glands
  • Minor: intraoral, pharyngeal, and nasal glands (600 to 1,000 glands distributed throughout the upper aerodigestive tract)

Description

  • Adult neoplasms
    • Benign: pleomorphic adenoma, Warthin tumor (adenolymphoma), oncocytoma, and monomorphic adenoma
    • Malignant: mucoepidermoid carcinoma, adenoid cystic carcinoma, acinic cell carcinoma, carcinoma ex pleomorphic adenoma, squamous cell carcinoma (SCC), adenocarcinoma
  • Total distribution of salivary gland neoplasms by type
    • Pleomorphic adenoma (most common): 45% overall
    • Monomorphic adenoma: 12% overall
    • Mucoepidermoid carcinoma: 12% overall
    • Adenoid cystic carcinoma: 6% overall
    • Remaining neoplasms: 25% overall
  • Distribution: parotid (80%); submandibular (10–15%); sublingual and minor (5–10%)
    • Parotid (80% benign; 20% malignant)
      • Pleomorphic adenoma: 60%
      • Monomorphic adenoma: 8%
      • Warthin tumor: 8%
      • Mucoepidermoid carcinoma: 12%
      • Adenoid cystic carcinoma: 5%
      • Adenocarcinoma and SCC: 5%
    • Submandibular (60% benign; 40% malignant)
      • Pleomorphic adenoma: 40%
      • Mucoepidermoid carcinoma: 10%
      • Adenoid cystic carcinoma: 20%
    • Lingual and minor salivary glands (40% benign; 60% malignant)
      • Pleomorphic adenoma: 40%
      • Mucoepidermoid carcinoma: 25%
      • Adenoid cystic carcinoma: 25%; generally, as the size of the gland decreases, the incidence of malignancy increases.
  • Pediatric neoplasms
    • These tumors are most frequently benign but may be malignant.
    • Benign: 65% of overall cases; the most common types are hemangiomas (before age 1 year) and pleomorphic adenomas (>1 year old). Warthin tumor, lymphoepithelioma, myoepithelioma, and basal cell adenoma can also occur (1)[B].
    • Malignant: 35% of overall cases; most common type is mucoepidermoid carcinoma. Other types seen include acinic cell carcinoma, adenoid cystic carcinoma, and sialoblastoma (1)[B].

Epidemiology

Incidence

  • 1.5/100,000 cases in individuals in the United States
  • ~700 deaths annually
  • Median age
    • Benign: 45 years
    • Malignant: 60 years
  • Gender predilection
    • Benign: female > male
    • Malignant: male = female

Prevalence

Make up 6–8% of all head and neck neoplasms (2)[A]

Etiology and Pathophysiology

Etiology and pathophysiology not fully understood; certain pathways and oncogenes have been implicated: p53, Bcl-2, PI3K/Akt, MDM2, VEGF, HGF, and ras.

  • Predominant/bicellular theory: Tumors arise from either the secretory duct reserve cell or the intercalated duct reserve cell.
  • Multicellular theory: Tumors arise from several cell types of origin within the salivary gland unit.

Genetics
Increased incidence of adenocarcinoma of parotid in Eskimos; otherwise, no known genetic pattern

Risk Factors

  • Tobacco and alcohol abuse associated with Warthin tumor
  • Alcohol increases likelihood ratio by 2:1.
  • Radiation has shown a 4-fold increased dose-related response in salivary gland cancer 15 to 20 years after treatment. Increased risk has also been reported in atomic bomb survivors.
  • EBV has been associated with lymphoepithelial carcinoma in Asians, but there is no evidence of causal association in other tumors.
  • Silica dust has been associated with a 2.5-fold increase in salivary gland neoplasia.
  • Kerosene-cooking fuel exposure
  • Nitrosamine exposure in rubber workers
  • Early menarche and nulliparity

General Prevention

Cessation of tobacco and alcohol use

There's more to see -- the rest of this topic is available only to subscribers.